Talazoparib Tosylate

 (TA-luh-ZOH-puh-rib TOH-suh-layt)

This page contains brief information about talazoparib tosylate and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials.

US Brand Name(s)
Talzenna
FDA Approved
Yes

FDA label information for this drug is available at DailyMed.

Use in Cancer

Talazoparib tosylate is approved to treat:

Talazoparib tosylate is also being studied in the treatment of other types of cancer.

More About Talazoparib Tosylate

Definition from the NCI Drug Dictionary - Detailed scientific definition and other names for this drug.

MedlinePlus Information on Talazoparib Tosylate - A lay language summary of important information about this drug that may include the following:

  • warnings about this drug,
  • what this drug is used for and how it is used,
  • what you should tell your doctor before using this drug,
  • what you should know about this drug before using it,
  • other drugs that may interact with this drug, and
  • possible side effects.

Drugs are often studied to find out if they can help treat or prevent conditions other than the ones they are approved for. This patient information sheet applies only to approved uses of the drug. However, much of the information may also apply to unapproved uses that are being studied.

Research Results and Related Resources

Targeted Cancer Therapies

Scientists Identify Potential Marker of Resistance to PARP Inhibitors

Clinical Trials Accepting Patients

Find Clinical Trials for Talazoparib Tosylate - Check for trials from NCI's list of cancer clinical trials now accepting patients.

  • Posted: February 28, 2019
  • Updated: March 19, 2019